{"meta":{"query_hash":"07b41bb9d2f3","filters":{"venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/07b41bb9d2f3","api":"https://metacan.xera.ac/api/v1/cohort?venue=Rinsho+yakuri%2FJapanese+Journal+of+Clinical+Pharmacology+and+Therapeutics"},"results":[{"id":"W2049129831","doi":"10.3999/jscpt.34.207s","title":"Comparison of Ethnic Difference in Pharmacological Parameter.","year":2003,"lang":"en","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital","funders":"","keywords":"Ethnic group; Pharmacology; Medicine; Internal medicine; Sociology; Anthropology","score_opus":0.3269756738721376,"score_gpt":0.5683442576836107,"score_spread":0.24136858381147314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049129831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932247,0.0008621383,0.00041160395,0.00006551253,0.000064299595,0.000015777352,0.00055870606,0.0000062007125,0.004791108],"genre_scores_gemma":[0.99818915,0.00017704318,0.00012120619,0.000035768193,0.000019318562,0.000015442944,0.00041088,0.000005930529,0.0010252275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995608,0.00013167475,0.000055109977,0.00008728663,0.00007691516,0.000088339715],"domain_scores_gemma":[0.99889815,0.00029523662,0.00023812827,0.00016458805,0.00022285481,0.00018096642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006987486,0.0001889635,0.0003097966,0.0005025388,0.0002872227,0.0003389269,0.00019031457,0.0002362207,0.0057224412],"category_scores_gemma":[0.0016853734,0.00008665907,0.0004351257,0.0005506764,0.00018990853,0.00024141594,0.00027099464,0.000281102,0.0009383426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004810989,0.0002842308,0.9579568,0.000087366294,0.00055050733,0.00093186187,0.0007639529,0.00008506691,0.0071488163,0.00041977476,0.0005768769,0.026383711],"study_design_scores_gemma":[0.000025571298,0.0002808009,0.9961389,0.000008481701,0.00011643975,0.0006179331,0.0005491244,0.00009959392,0.0006721247,0.000105682135,0.0013769445,0.000008530976],"about_ca_topic_score_codex":0.001701537,"about_ca_topic_score_gemma":0.0014750698,"teacher_disagreement_score":0.0057224412,"about_ca_system_score_codex":0.00017515771,"about_ca_system_score_gemma":0.0002415396,"threshold_uncertainty_score":0.019143462},"labels":[],"label_agreement":null},{"id":"W2508720848","doi":"10.3999/jscpt.43.91","title":"S2-4. Development of Exon Skipping Therapy for Duchenne Muscular Dystrophy Using Patient-Derived Cells","year":2012,"lang":"en","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Exon skipping; Medicine; Muscular dystrophy; Exon; Bioinformatics; Internal medicine; Genetics; Biology; Gene; Alternative splicing","score_opus":0.07570945938194525,"score_gpt":0.39541107432371864,"score_spread":0.3197016149417734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508720848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382838,0.004470535,0.024800774,0.0011472681,0.0005477589,0.00096297596,0.0065481085,0.0007516645,0.022487069],"genre_scores_gemma":[0.9525855,0.002931733,0.016208537,0.0004118602,0.00005736719,0.0006381242,0.0077727586,0.00010328508,0.01929087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981135,0.000041011823,0.000028856522,0.000036398033,0.000054176613,0.000028178118],"domain_scores_gemma":[0.99992955,0.000016864444,0.000009385761,0.000012771576,0.000015769887,0.000015608726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039150903,0.0004597133,0.0004187981,0.00036225302,0.0002908996,0.0004222723,0.00042757049,0.00073046854,0.00548903],"category_scores_gemma":[0.00019031204,0.00019069585,0.00055978243,0.00021560317,0.00022969455,0.00020049921,0.00021833678,0.00074678723,0.0019671556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005615986,0.00031177246,0.0008985809,0.0001419143,0.0000289009,0.00059517345,0.00006843848,0.00050928444,0.9784121,0.0009954583,0.0013968181,0.016079847],"study_design_scores_gemma":[0.00024570135,0.0011861704,0.0022272049,0.000022761844,0.00008500716,0.0010444901,0.00003876065,0.0014703014,0.9681238,0.00021551787,0.02533099,0.0000092675],"about_ca_topic_score_codex":0.00064813875,"about_ca_topic_score_gemma":0.0008197126,"teacher_disagreement_score":0.00548903,"about_ca_system_score_codex":0.00022749863,"about_ca_system_score_gemma":0.0005725594,"threshold_uncertainty_score":0.018362582},"labels":[],"label_agreement":null},{"id":"W2519597521","doi":"10.3999/jscpt.44.47","title":"Current Status and Future Expectations of Using Remote Source Data Verification for Improving the Efficiency of Clinical Trials","year":2013,"lang":"en","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Innovative Microfluidic and Catalytic Techniques Innovation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Association of Canadian Archivists","funders":"","keywords":"Medicine","score_opus":0.2168482143777374,"score_gpt":0.4907498686909708,"score_spread":0.27390165431323343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519597521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.556863,0.057632484,0.024134602,0.3392571,0.0010446394,0.0006818726,0.0008181925,0.0005854824,0.018982602],"genre_scores_gemma":[0.95734227,0.012590224,0.01639449,0.011533651,0.0008726485,0.00031162487,0.0004088863,0.00004813327,0.00049813563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9085362,0.06638873,0.009844419,0.0026304547,0.009582971,0.003017192],"domain_scores_gemma":[0.4958282,0.26927486,0.10595689,0.012019013,0.060307633,0.056613404],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17153776,0.00037443012,0.00050148775,0.0014482271,0.00065937423,0.004872693,0.0027337137,0.0028724517,0.0041250046],"category_scores_gemma":[0.26750636,0.0004879666,0.000877294,0.0020556492,0.0020813013,0.0063172434,0.001984789,0.0022024843,0.0006750221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018907387,0.0013476594,0.62415963,0.0054994333,0.00026973322,0.0006422457,0.00503247,0.0021216504,0.0025904723,0.0030055295,0.014004489,0.33943594],"study_design_scores_gemma":[0.00063062046,0.0049098697,0.8926378,0.007533419,0.00039403728,0.0024563225,0.01891007,0.016814565,0.0031157644,0.0040322333,0.048234314,0.00033104804],"about_ca_topic_score_codex":0.0023849597,"about_ca_topic_score_gemma":0.0029764005,"teacher_disagreement_score":0.82846224,"about_ca_system_score_codex":0.0031270087,"about_ca_system_score_gemma":0.01312489,"threshold_uncertainty_score":0.9071892},"labels":[],"label_agreement":null},{"id":"W2564551262","doi":"10.3999/jscpt.42.305","title":"2. Pharmacokinetics and Drug Interaction of New Anticoagulants: Direct Thrombin Inhibitor and Factor Xa Inhibitors","year":2011,"lang":"en","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Warfarin; Atrial fibrillation; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Stroke (engine); Anticoagulant; Drug; Pharmacokinetics; Pharmacology; Intensive care medicine; Internal medicine; Thrombin","score_opus":0.1956427213105497,"score_gpt":0.45110791991383664,"score_spread":0.255465198603287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564551262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005557261,0.98520744,0.0016153323,0.00097103574,0.0004273293,0.000045157853,0.0002581451,0.00005562128,0.005862711],"genre_scores_gemma":[0.026098918,0.9612691,0.0022481075,0.0010697382,0.0009502561,0.000086252425,0.00051122054,0.00001422311,0.0077522406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995623,0.000074082214,0.00007747286,0.000058328525,0.00019249287,0.000035384244],"domain_scores_gemma":[0.9997482,0.00007401936,0.00006676686,0.0000075568964,0.00009104362,0.00001249328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004251603,0.00069127005,0.0010965656,0.0010761608,0.00022846268,0.00086951157,0.0004162097,0.00072940846,0.0031555973],"category_scores_gemma":[0.0005530213,0.00022508754,0.00093013834,0.0009780243,0.00018489912,0.00068108767,0.00030069632,0.00088624307,0.001237526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004462451,0.00029229908,0.003859995,0.020116363,0.00040005083,0.001650194,0.00017025687,0.001291869,0.018243402,0.002736927,0.03495719,0.91583526],"study_design_scores_gemma":[0.0001074511,0.001074776,0.016751835,0.0024662875,0.00087211584,0.01679537,0.00012415787,0.0014048503,0.011812804,0.0018233601,0.94668245,0.000084557265],"about_ca_topic_score_codex":0.0013148035,"about_ca_topic_score_gemma":0.0013307419,"teacher_disagreement_score":0.0031555973,"about_ca_system_score_codex":0.00036973305,"about_ca_system_score_gemma":0.00081932754,"threshold_uncertainty_score":0.010556519},"labels":[],"label_agreement":null},{"id":"W3153857155","doi":"10.3999/jscpt.41.101","title":"","year":2010,"lang":"","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Disease; Biomarker; Clinical trial; Positron emission tomography; Neuroimaging; Drug development; Pathology; Biomarker discovery; Oncology; Drug; Radiology; Pharmacology; Psychiatry","score_opus":0.09866541237271534,"score_gpt":0.4846769160519644,"score_spread":0.3860115036792491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153857155","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015243398,0.174714,0.07672513,0.021345004,0.011823166,0.0008908039,0.007933628,0.0031289712,0.6881959],"genre_scores_gemma":[0.13646324,0.13955986,0.09030616,0.014314474,0.0052474057,0.0013217382,0.01163048,0.00087220914,0.60028446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979949,0.00040789365,0.0001415886,0.0003948307,0.0009286915,0.0001321919],"domain_scores_gemma":[0.9977087,0.00037797773,0.00022324784,0.0003411247,0.0010733857,0.000275545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027735268,0.0009893615,0.0010879796,0.0023260578,0.0010754126,0.003948461,0.0011424386,0.0019304914,0.07104032],"category_scores_gemma":[0.0041927504,0.0003444696,0.0005519181,0.0029651935,0.0012413557,0.002495175,0.0022736,0.0017662243,0.054095164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032063058,0.00011251457,0.0040128236,0.0010300449,0.00007145235,0.00049665495,0.0002570513,0.00023957368,0.013550205,0.04407845,0.11187559,0.82395506],"study_design_scores_gemma":[0.000023420584,0.00011080476,0.0027171632,0.00022651083,0.000028115559,0.0008293288,0.00012179796,0.00016411996,0.0032866267,0.009384286,0.9830831,0.000024861161],"about_ca_topic_score_codex":0.0014262313,"about_ca_topic_score_gemma":0.0015991955,"teacher_disagreement_score":0.92895967,"about_ca_system_score_codex":0.0013490919,"about_ca_system_score_gemma":0.0021338155,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4414600281","doi":"10.3999/jscpt.56.5_226","title":"日本臨床薬理学会海外研修員報告：研修完了報告書","year":2025,"lang":"ja","type":"article","venue":"Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Sputum; Public health; Acquired immune system; Health professionals","score_opus":0.06008663524680006,"score_gpt":0.41523651701384834,"score_spread":0.35514988176704826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414600281","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21661587,0.22744726,0.029372154,0.407172,0.04267028,0.0006354321,0.0021393204,0.00069717324,0.07325047],"genre_scores_gemma":[0.6231805,0.13554671,0.017348202,0.01634978,0.01637289,0.00039167574,0.0009528369,0.00022871858,0.18962862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992779,0.00020572006,0.000028339557,0.0001446886,0.00019575265,0.00014768649],"domain_scores_gemma":[0.99709845,0.00023865551,0.00031433025,0.00006170446,0.0007381005,0.0015487851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021753854,0.0004412851,0.0005055785,0.00058926834,0.0007757214,0.0012892945,0.00045796833,0.0007064709,0.012848678],"category_scores_gemma":[0.0019121771,0.00016756963,0.000391708,0.0004198776,0.0011428691,0.0007565514,0.0012841106,0.0018824834,0.004871611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022618878,0.00047165668,0.039433632,0.0017224996,0.00010107168,0.0021468792,0.0052323826,0.00051650644,0.13921326,0.01990713,0.26052245,0.52847064],"study_design_scores_gemma":[0.00010877212,0.0016821183,0.03105139,0.000659578,0.00007664469,0.004545955,0.004048992,0.00037504453,0.07156639,0.0059326207,0.87984025,0.00011227277],"about_ca_topic_score_codex":0.0023256883,"about_ca_topic_score_gemma":0.0028577608,"teacher_disagreement_score":0.012848678,"about_ca_system_score_codex":0.0011303093,"about_ca_system_score_gemma":0.0018745332,"threshold_uncertainty_score":0.042983115},"labels":[],"label_agreement":null}]}